Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose PEGASYS and Copegus in Heavy Patients with HCV Genotype 1
NCT00077649Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2004
- Primary completion
- Dec 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Roche. Started Jan 2004; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00077649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077649.